REG - ConvaTec Group PLC - Director/PDMR Shareholding

ConvaTecAnnouncement

29/03/2019 14:50

RNS Number : 5098U
ConvaTec Group PLC
29 March 2019
 


29 March 2019
ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 28 March 2019, the Company's Chief Financial Officer and a PDMR, sold and bought 165,000 Shares at a price of £1.4026 to facilitate the transfer of Shares between two broking accounts where the beneficial interest in the Shares did not change.
Mr Schulkes' shareholding remains unchanged at 165,000 Shares.
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Frank Schulkes




2


Reason for the notification




a)


Position/Status


Chief Financial Officer




b)


Initial notification/Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


ConvaTec Group Plc




b)


LEI


213800LS272L4FIDOH92




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
Identification code


Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
GB00BD3VFW73




b)


Nature of the transaction


  Sale and purchase of Shares on 28 March 2019
 




c)


Price(s) and volume(s)


Price(s)
  £1.4026
 


Volume(s)
  165,000
 
 




d)


Aggregated information
- Aggregated volume 
- Price


 
165,000
  £231,429




e)


Date of the transaction


28 March 2019




f)


Place of the transaction


London Stock Exchange, Main Market (XLON)



 
 
 



 
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec                        +44 (0)7770 842 226
Alastair Elwen, Finsbury                                                                       +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec                                     +44 (0)7500 141 435
Mark Reynolds, Director Investor Relations, ConvaTec                        +44 (0)7551 036 625
investorrelations@convatec.com
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFELVIIAFIA